Tremelimumab (anti-CTLA-4)

製品コード：A2021 Batch: A202104

Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.

製品説明

CAS No.	745013-59-6
Formulation	PBS Buffer, PH 7.4
Isotype	Human IgG2
Source	HEK293 Cells
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping	Shipped under low temperature conditions
Purity	99.87%
Protein concentration	8.05mg/ml
Endotoxin Level	<1 EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。